Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Sep 30, 2024 | FY 2023Sep 30, 2023 | FY 2022Sep 30, 2022 | FY 2021Sep 30, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | -- | -- | 0.00 | 0.00 |
| Gross Profit | -- | -- | 0.00 | 0.00 |
| Selling General And Administration | 692,885 | 381,716 | 759,098 | 621,152 |
| General And Administrative Expense | 692,885 | 381,716 | 759,098 | 621,152 |
| Other Operating Expenses | 703,952 | 245,341 | 579,222 | 635,748 |
| Operating Expense | 1.4M | 627,057 | 1.3M | 1.3M |
| Operating Income | -1.4M | -627,057 | -1.3M | -1.3M |
| EBIT | -1.4M | -627,057 | -1.3M | -1.3M |
| Interest Income | 9,289 | 2,376 | 1,997 | 1,187 |
| Interest Income Non Operating | 9,289 | 2,376 | 1,997 | 1,187 |
| Net Interest Income | 9,289 | 2,376 | 1,997 | 1,187 |
| Other Income Expense | -643,865 | -170,359 | -715,667 | 316,589 |
| Other Non Operating Income Expenses | 58,489 | 164,229 | 370,794 | 349,676 |
| Special Income Charges | -717,378 | -381,649 | -1.0M | -8,469 |
| Write Off | 0.00 | 42,706 | 0.00 | 0.00 |
| Gain On Sale Of Security | 15,024 | 47,061 | -48,415 | -24,618 |
| Pretax Income | -2.0M | -795,040 | -2.1M | -939,124 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -2.0M | -795,040 | -2.1M | -939,124 |
| Net Income From Continuing Operation Net Minority Interest | -2.0M | -795,040 | -2.1M | -939,124 |
| Net Income Including Noncontrolling Interests | -2.0M | -795,040 | -2.1M | -939,124 |
| Net Income Common Stockholders | -2.0M | -795,040 | -2.1M | -939,124 |
| Net Income | -2.0M | -795,040 | -2.1M | -939,124 |
| EBITDA | -1.4M | -627,057 | -1.3M | -1.3M |
| Normalized EBITDA | -694,483 | -292,469 | -251,859 | -1.2M |
| Reconciled Depreciation | -- | -- | 0.00 | 0.00 |
| Basic EPS | -0.05 | -0.02 | -0.07 | -0.03 |
| Diluted EPS | -0.05 | -0.02 | -0.07 | -0.03 |
| Basic Average Shares | 40.6M | 31.8M | 30.5M | 27.9M |
| Diluted Average Shares | 40.6M | 31.8M | 30.5M | 27.9M |
| Total Unusual Items | -702,354 | -334,588 | -1.1M | -33,087 |
| Total Unusual Items Excluding Goodwill | -702,354 | -334,588 | -1.1M | -33,087 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.3M | -460,452 | -965,529 | -906,037 |
| Diluted NI Availto Com Stockholders | -2.0M | -795,040 | -2.1M | -939,124 |
| Gain On Sale Of Ppe | -- | -- | 0.00 | 0.00 |
| Impairment Of Capital Assets | 717,378 | 338,943 | 1.0M | 8,469 |
| Net Income Continuous Operations | -2.0M | -795,040 | -2.1M | -939,124 |
| Net Non Operating Interest Income Expense | 9,289 | 2,376 | 1,997 | 1,187 |
| Other Gand A | 176,817 | 187,483 | 219,579 | 225,000 |
| Reconciled Cost Of Revenue | -- | -- | 0.00 | 0.00 |
| Salaries And Wages | 516,068 | 194,233 | 539,519 | 396,152 |
| Total Expenses | 1.4M | 627,057 | 1.3M | 1.3M |
| Line Item | FY 2024Sep 30, 2024 | FY 2023Sep 30, 2023 | FY 2022Sep 30, 2022 | FY 2021Sep 30, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 709,647 | 135,203 | 403,093 | 412,676 |
| Cash Cash Equivalents And Short Term Investments | 709,647 | 139,703 | 564,892 | 412,676 |
| Cash Financial | 709,647 | 135,203 | 403,093 | 412,676 |
| Other Short Term Investments | 0.00 | 4,500 | 161,799 | 0.00 |
| Accounts Receivable | 38,360 | 17,030 | 26,707 | 43,953 |
| Receivables | 38,360 | 17,030 | 26,707 | 170,000 |
| Prepaid Assets | 105,372 | 14,197 | 107,030 | 24,784 |
| Current Assets | 853,379 | 199,930 | 932,710 | 607,460 |
| Net PPE | 6.9M | 6.9M | 7.0M | 7.7M |
| Total Non Current Assets | 6.9M | 7.0M | 7.2M | 7.8M |
| Total Assets | 7.8M | 7.2M | 8.1M | 8.4M |
| Accounts Payable | 498,199 | 246,582 | 480,299 | 214,163 |
| Payables | 1.1M | 883,687 | 865,873 | 428,894 |
| Payables And Accrued Expenses | 1.1M | 883,687 | 865,873 | 428,894 |
| Other Current Liabilities | 107,997 | -- | 238,302 | 33,050 |
| Current Liabilities | 1.2M | 883,687 | 1.1M | 461,944 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 1.2M | 883,687 | 1.1M | 461,944 |
| Common Stock | 26.9M | 24.9M | 24.9M | 24.3M |
| Capital Stock | 26.9M | 24.9M | 24.9M | 24.3M |
| Retained Earnings | -24.4M | -22.4M | -21.6M | -19.6M |
| Gains Losses Not Affecting Retained Earnings | 4.1M | 3.7M | 3.7M | 3.2M |
| Other Equity Adjustments | 4.1M | 3.7M | 3.7M | 3.2M |
| Common Stock Equity | 6.6M | 6.3M | 7.0M | 7.9M |
| Stockholders Equity | 6.6M | 6.3M | 7.0M | 7.9M |
| Total Equity Gross Minority Interest | 6.6M | 6.3M | 7.0M | 7.9M |
| Total Capitalization | 6.6M | 6.3M | 7.0M | 7.9M |
| Net Tangible Assets | 6.6M | 6.3M | 7.0M | 7.9M |
| Tangible Book Value | 6.6M | 6.3M | 7.0M | 7.9M |
| Working Capital | -361,496 | -683,757 | -171,465 | 145,516 |
| Invested Capital | 6.6M | 6.3M | 7.0M | 7.9M |
| Share Issued | 47.7M | 31.9M | 31.8M | 29.8M |
| Ordinary Shares Number | 47.7M | 31.9M | 31.8M | 29.8M |
| Current Deferred Assets | 0.00 | 29,000 | 0.00 | 0.00 |
| Duefrom Related Parties Current | -- | -- | 0.00 | 126,047 |
| Dueto Related Parties Current | 608,679 | 637,105 | 385,574 | 214,731 |
| Non Current Accounts Receivable | -- | -- | 41,186 | 36,052 |
| Non Current Prepaid Assets | 75,889 | 81,415 | 94,720 | 27,662 |
| Other Equity Interest | -- | 85,000 | -- | -- |
| Restricted Cash | -- | 0.00 | 234,081 | 0.00 |
| Line Item | FY 2024Sep 30, 2024 | FY 2023Sep 30, 2023 | FY 2022Sep 30, 2022 | FY 2021Sep 30, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -1.3M | -369,853 | -435,882 | -1.3M |
| Cash Flow From Continuing Operating Activities | -1.3M | -369,853 | -435,882 | -1.3M |
| Depreciation And Amortization | -- | -- | 0.00 | 0.00 |
| Depreciation Amortization Depletion | -- | -- | 0.00 | 0.00 |
| Stock Based Compensation | 336,735 | 0.00 | 365,300 | 202,304 |
| Deferred Tax | -- | -- | -341,966 | 0.00 |
| Deferred Income Tax | -- | -- | -341,966 | 0.00 |
| Change In Working Capital | -251,015 | 254,700 | 498,655 | -260,711 |
| Changes In Account Receivables | -21,287 | 65,875 | 17,502 | -30,622 |
| Change In Receivables | -21,287 | 65,677 | 142,796 | -157,771 |
| Change In Payables And Accrued Expense | -188,553 | 350,948 | 182,447 | -72,979 |
| Change In Payable | -188,553 | 350,948 | 182,447 | -72,979 |
| Change In Other Current Liabilities | 0.00 | -234,081 | 234,081 | -83,070 |
| Other Non Cash Items | -55,789 | -164,229 | -370,794 | -349,676 |
| Capital Expenditure | -369,274 | -452,748 | -- | -3.3M |
| Purchase Of PPE | -369,274 | -452,748 | 12,341 | -3.3M |
| Net PPE Purchase And Sale | -369,274 | -452,748 | 12,341 | -3.3M |
| Sale Of Investment | 20,625 | 216,232 | 0.00 | 0.00 |
| Net Investment Purchase And Sale | 20,625 | 216,232 | 0.00 | 0.00 |
| Investing Cash Flow | -343,205 | -224,292 | -49,243 | -3.3M |
| Cash Flow From Continuing Investing Activities | -343,205 | -224,292 | -49,243 | -3.3M |
| Issuance Of Capital Stock | 2.4M | 0.00 | 750,000 | 4.4M |
| Net Common Stock Issuance | 2.4M | 0.00 | 750,000 | 4.4M |
| Financing Cash Flow | 2.2M | 106,965 | 729,630 | 4.7M |
| Cash Flow From Continuing Financing Activities | 2.2M | 106,965 | 729,630 | 4.7M |
| Effect Of Exchange Rate Changes | -1,942 | -14,791 | -20,007 | 8,065 |
| Changes In Cash | 576,386 | -487,180 | 244,505 | 42,548 |
| Beginning Cash Position | 135,203 | 637,174 | 412,676 | 362,063 |
| End Cash Position | 709,647 | 135,203 | 637,174 | 412,676 |
| Free Cash Flow | -1.7M | -822,601 | -435,882 | -4.6M |
| Asset Impairment Charge | 717,378 | 381,649 | 1.0M | 8,469 |
| Change In Account Payable | -114,574 | 147,863 | 11,604 | -48,373 |
| Change In Prepaid Assets | -41,175 | 72,156 | -60,669 | 53,109 |
| Common Stock Issuance | 2.4M | 0.00 | 750,000 | 4.4M |
| Depreciation | -- | -- | 0.00 | 0.00 |
| Gain Loss On Investment Securities | -8,625 | 30,052 | 416.00 | -- |
| Gain Loss On Sale Of PPE | -- | -- | 0.00 | 0.00 |
| Net Income From Continuing Operations | -2.0M | -795,040 | -2.1M | -939,124 |
| Net Other Financing Charges | -172,560 | 85,000 | -20,370 | -368,215 |
| Net Other Investing Changes | 5,444 | 12,224 | -61,584 | -27,563 |
| Operating Gains Losses | -8,625 | 30,052 | 416.00 | -- |
| Proceeds From Stock Option Exercised | 0.00 | 21,965 | 0.00 | 626,805 |
| Sale Of PPE | -- | -- | 12,341 | 0.00 |
| Unrealized Gain Loss On Investment Securities | -7,500 | -76,985 | 84,485 | 0.00 |